Insight into the Development of PET Radiopharmaceuticals for Oncology

While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Lau, Joseph, Rousseau, Etienne, Kwon, Daniel, Lin, Kuo-Shyan, Bénard, François, Chen, Xiaoyuan
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281377/
https://ncbi.nlm.nih.gov/pubmed/32455729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051312
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items